Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.
 |
Vidyya |
|
Ars Medica Home |
|
Vidyya Archives |
|
Search Vidyya |
|
Ex Libris |
|
Subscriptions |
|
About Vidyya |
|
|
|
In Today's Vidyya Interesting new research sheds light on the addictive properties of marijuana |
|
Researchers Find That Animals Exposed To Marijuana's Active Component Will Self-Administer The Drug Scientists at the National Institute on Drug Abuse (NIDA) have demonstrated that laboratory animals will self-administer marijuana's psychoactive component, THC (delta-9-tetrahydrocannabinol), in doses equivalent to those used by humans who smoke the drug. Self-administration of drugs by animals, long considered a model of human drug-seeking behavior, is characteristic of virtually all addictive and abused drugs. More... |
|
Facts About Marijuana - A Guide For Parents This guide, from the National Institute on Drug Abuse, is an excellent information source for parents. As the number of young people who use marijuana has increased, the number who view the drug as harmful has decreased. Among high school seniors surveyed in 1997, current marijuana use has increased by about 72 percent since 1991. The proportion of those seniors who believe regular use of marijuana is harmful has dropped by about 26 percent since 1991. More... |
|
FDA Meets To Receive Public Testimony On Immune Based Therapies For HIV
Over the past 14 months, AIDS treatment activists, many of whom are members of The HIV Immune Based Therapy Working Group have placed pressure on the Food and Drug Administration regarding the FDA process, procedures and review of immune based therapies for the treatment of HIV disease. In a surprise turn of events by the FDA Antiviral Committee, a meeting took place yesterday to discuss these issues. More... |
|
Transgenic Mice Aid Research Into Deadly Cancer Scientists will be better able to fight Burkitt's lymphoma, a rare but deadly cancer that attacks children and AIDS patients, now that they have achieved a decades-long goal of genetically engineering mice to develop the disease. More... |
|
Abstracts Of Interest - Therapy Of Non-Hodgkin's Lymphoma Catch up on a month's reading in one place with these abstracts from the last 30 days, all of which focus on the therapy of Non-Hodgkin's lymphoma. Topics cover salvage therapy, new clinical trial results and more. More... |
Ars Medica Home | Ex Libris | Vidyya |
Subscription Information | About Vidyya | Vidyya Archives |
Editor: Susan K. Boyer, RN
© RAmEx Ars Medica, Inc. All rights reserved.